Ostex International, Inc.

As of June 30, 2003, Ostex International, Inc. was acquired by Alere Inc. Ostex International, Inc. engages in the development and commercialization of products associated with osteoporosis and other collagen-related diseases. Its products include Ostex lead product, the Osteomark N-telopeptides of Type I collagen (NTx) test, that incorporates technology for the management of osteoporosis. The Osteomark NTx test is a non-invasive test that quantitatively indicates the level of bone resorption. The company has collaborative relationships with laboratories and distributors, and markets its Osteomark NTx Point-of-Care device to pharmaceutical companies. The company was founded in 1989 and is based in Seattle, Washington.